Do not take DORMONOCT:
- if you are hypersensitive (allergic) to loprazolam, benzodiazepines or any of the other ingredients of DORMONOCT. Signs of an allergic reaction include: a rash, itching, swallowing or breathing problems or swelling of your lips, face, throat or tongue.
- if you have serious breathing problems (severe respiratory insufficiency).
- if you have a long term (chronic) condition in which the muscles become weak and tire easily (called myasthenia gravis).
- if you stop breathing for short periods during sleep (called sleep apnoea syndrome)
- if you have serious liver problems.
DORMONOCT should not be given to children.
Take special care with DORMONOCT:
- if you are elderly or debilitated, as there is a risk of over-sedation, shallow breathing and unsteadiness when walking. The initial dosage should be reduced.
- If you have shallow breathing (respiratory insufficiency), in order to avoid aggravation of the problem. The dosage should be reduced.
- if you have lung problems.
- if you have kidney or liver problems.
- if you suffer from anxiety (nervousness) accompanied by an underlying depressive disorder (feelings of deep sadness and unworthiness).
- if you are taking barbiturates (medicines used to treat epilepsy) or other depressants (medicines for depression).
- if you are drinking alcohol, as it has an additive effect.
- if you suffer from a psychotic illness (a severe mental condition in which the person loses contact with reality and is unable to think and judge clearly). DORMONOCT should not be used alone to treat depression or anxiety with depression, as suicide may be precipitated in such patients.
- if you have a history of alcohol or drug abuse.
Dependence: DORMONOCT can be addictive, especially with prolonged use and high doses. The risk of dependence is also greater in patients with a history of alcohol or drug abuse. Once dependence has developed, abrupt termination of treatment is accompanied by withdrawal symptoms (headaches, muscle pain, extreme anxiety, tension, restlessness, confusion and irritability).
Rebound effects: A temporary syndrome may occur when treatment is withdrawn, whereby the symptoms that led to treatment with DORMONOCT recur in an enhanced form. It may be accompanied by other reactions including mood changes, anxiety and restlessness. Since the risk of withdrawal or rebound effects is greater after abrupt discontinuation of treatment, the dose is decreased gradually.
Tolerance: Some loss of hypnotic effects may develop after repeated use for a few weeks.
Amnesia: You may experience anterograde amnesia (loss of memory for events following some trauma). To reduce this risk, ensure that you are able to have an uninterrupted sleep of 7 – 8 hours.
Paradoxical reactions: You may experience psychiatric and paradoxical reactions (such as restlessness, agitation, irritability, aggressiveness, delusion, rages, nightmares, hallucinations, inappropriate behaviour). If these occur, DORMONOCT should be discontinued. They are more likely to occur in children and the elderly.
If you are not sure if any of the above apply to you, talk to your doctor or pharmacist.
Taking DORMONOCT with food and drink: Do not drink alcohol or take medicines that contain alcohol while being treated with DORMONOCT. This is because alcohol can increase the effects of DORMONOCT.